Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Artrya.
RELATED STOCKHEAD STORIES
News
ASX Quarterly Wrap: Brainchip progresses AI chip commercialisation, RBX grabs tasty James Bay lithium projects
News
In Case You Missed It: A high flying copper stock and a vanadium offtake deal
Health & Biotech
ASX Health Stocks: Proteomics’ blood test PromarkerD effective with diabetes drug Canagliflozin
Health & Biotech
ASX Health Stocks: These three ASX biotechs get to strut their stuff with Bell Potter and Nature Portfolio
News
LAST ORDERS: A mildly seditious look back at what happened here, and there, today
News
ASX Small Caps Lunch Wrap: Who’s reeling from a head knock this morning?
News
Top 10 at 10: Friday’s top (and bottom) ASX stocks in early trade
Stockhead TV
Artrya: A big data approach to the early detection of heart disease
Health & Biotech
ASX Health Stocks: Artrya goes to America while EZZ goes live on TikTok China
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX Health Stocks: CBD gel could become cornerstone therapy for hand arthritis, says Avecho
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
News
